Condition
Autologous Fat Grafting
Total Trials
5
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 1 (1)
Trial Status
Withdrawn1
Terminated1
Active Not Recruiting1
Unknown1
Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT06343831Not ApplicableRecruitingPrimary
Quantitative Assessment of Autologous Fat Transfer
NCT07186322Not ApplicableActive Not RecruitingPrimary
Autologous Fat Grafting in Upper Limb Burns Scars
NCT04906811Not ApplicableTerminatedPrimary
Prospective Comparison of Revolve™ and AuraGen 123 With AuraClens™ in Autologous Fat Grafting to the Breast
NCT03544593Not ApplicableUnknownPrimary
The Volumetric Analysis of Fat Grafting
NCT01750424Phase 1Withdrawn
3-D Imaging Assessment of Scar Formation and Would Healing in Fat Grafted vs Non-Fat Grafted Facial Reconstruction Wound Sites
Showing all 5 trials